Over the last two decades, great strides have been made in the treatment of
acute lymphoblastic leukemia (ALL). This progress has been paralleled by a
dvances in diagnosis. In addition to morphology and cytochemistry the diagn
ostic and prognostic importance of immunophenotypic and genetic features is
becoming increasingly apparent. This article reviews the clinical and morp
hologic features, immunophenotypic classification, and karyotypic abnormali
ties of ALL, and discusses how these aspects relate to the diagnosis of ALL
.